Corporate Profile || Product Profile || Contract Synthesis || Contract Research Work
SR. NO
PRODUCT
REGULATORY STATUS
    TDP EDMF US-DMF JDMF COS
1 ACECLOFENAC         
2 BENZARONE        
3 BENZBROMARONE      
4 BENZIODARONE          
5 BEVENTOLOL HCL        
6 EBASTINE    
 
7 FAMOTIDINE  USP/EP/BP/JP  
8 GLIMEPIRIDE      
9 LORATADINE      
10 MEFENAMIC ACID  
   
11 NIFEDIPINE IP/BP/USP/EP      
12 PROTRYPTILLINE HCL    
   
13 QUETIAPINE FUMARATE    
   
14 SODIUM ALENDRONATE        
15 TAMSULOSIN HCL          
16 TRAMADOL HCL      
17 ZALTOPROFEN        
18 ZOLPIDEM TARTRATE EP/BP      

Pharma Intermediates

1 ZOLPIDIC ACID - (6-Methyl-2- (-4-methylphenyl)-imidazo [1,2-a] pyridine-3-acetic acid) - Zolpidem Tartrate Intermediate [CAS NO: 189005-44-5]          
2 6-methyl-2-(4-methylphenyl)-imidazo[1,2-a]pyridine-3- acetonitrile - Zolpidem Tartrate Intermediate          
3 11-piperizinyl-dibenzo[b,f][1,4] thiazepine dihydrochloride - Quetiapine Intermediate
       
4 4-amino-5-chloro-2-ethoxy Benzoic acid - MOSAPRIDE INTERMEDIATE [CAS NO: 108282-38-8]          
5 2-Aminomethyl-(4-Fluorobenzyl)morpholine - MOSAPRIDE INTERMEDIATE [CAS NO: 112914-13-3]          
6 Thiopinone          
7 4-Hydroxy coumarin - Warfarin intermediate [CAS NO: 1076-38-6]          
8 2-(1,2-Benzisoxazol-3-yl)acetic acid - Zonisamide Intermediate - [CAS NO: 4865-84-3]          

Under Development As on Aug. 2010

SR.
NO.
PRODUCT TECHNOLOGY STATUS 
     
1 TAMSULOSIN HCL Under development
2 Mosapride citrate Dihydrate Under development
3 Zonisamide Under development

Tonira Pharma Limited, assumes no liability for any infringement of patent or any other rights. The patent position in the concerned country should be verified by the customer. None of the products will be supplied to countries in which this could be in conflict with existing patents. However the final responsibility lies with the buyer.


PRODUCT PROFILE